CXC chemokines: Potential biomarker and immunotherapeutic target for uterine corpus endometrial carcinoma
Κύριοι συγγραφείς: | Guang Wang, Juan Fu, Mulin Liu, Qin Zheng |
---|---|
Μορφή: | Άρθρο |
Γλώσσα: | English |
Έκδοση: |
Public Library of Science (PLoS)
2024-01-01
|
Σειρά: | PLoS ONE |
Διαθέσιμο Online: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10793908/?tool=EBI |
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
CXC chemokines: Potential biomarker and immunotherapeutic target for uterine corpus endometrial carcinoma.
ανά: Guang Wang, κ.ά.
Έκδοση: (2024-01-01) -
Prognostic Biomarkers and Immunotherapeutic Targets Among CXC Chemokines in Pancreatic Adenocarcinoma
ανά: Jiacheng Huang, κ.ά.
Έκδοση: (2021-08-01) -
The role of CXC cytokines as biomarkers and potential targets in hepatocellular carcinoma
ανά: Yonghui Wang, κ.ά.
Έκδοση: (2020-01-01) -
The Role of CXC Chemokines in Cardiovascular Diseases
ανά: Xiyi Lu, κ.ά.
Έκδοση: (2022-05-01) -
Depleted-MLH1 Expression Predicts Prognosis and Immunotherapeutic Efficacy in Uterine Corpus Endometrial Cancer: An In Silico Approach
ανά: Tesfaye Wolde, κ.ά.
Έκδοση: (2024-02-01)